Canine parvovirus (CPV) and feline panleukopenia virus (FPV) are over 98% similar in DNA sequence but have specific host range, antigenic, and hemagglutination (HA) properties which were located within the capsid protein gene. In vitro mutagenesis and recombination were used to prepare 16 different recombinant genomic clones, and viruses derived from those clones were analyzed for their in vitro host range, antigenic, and HA properties. CPV is closely related to FPV, RPV, and MEV. Those viruses are all >98% similar in DNA sequence within the capsid protein gene (9, 27, 32, 33, 42, 43) , and studies with monoclonal antibodies (MAbs) indicate that the viruses are very similar antigenically (36, 38, 56). However, there is a specific epitope on CPV which is not present on the other viruses, and there are also epitopes which can distinguish FPV and MEV isolates from CPV (36, 38, 56 Studies of recombinants between CPV and FPV indicate that sequence differences which affect the canine host range and antigenic type of CPV are located within the VP1 and VP2 genes, between 59 and 73 map units (m.u.) (32, 33, 37). There are eight coding nucleotide differences in the 59 to 100 m.u. region between the prototype strains CPV-d and 39) . Five of those are phylogenetically conserved among CPV isolates and differ in the sequences of the viruses from other species (32, 33) . Earlier analysis of CPV/FPV recombinants indicated that the pH dependence of HA was determined by the region between 59 to 80 m.u. and that it was specifically affected by VP2 residue 375 (32, 33).
Canine parvovirus (CPV) and feline panleukopenia virus (FPV) are classified as host range variants among the feline parvoviruses of the genus Parvovirus in the family Parvoviridae (49) . CPV was first recognized in a number of countries during 1978 (3, 23 ; reviewed in references 10, 31, 41, and 48). Retrospective serological studies indicated that CPV was a new infectious agent of canids, the first serological evidence of canine infection by CPV being from sera collected in Europe around 1974 or 1976 (reviewed in references 10, 31, 41, and 48) . Diseases associated with FPV, mink enteritis virus (MEV), or raccoon parvovirus (RPV) in cats, minks, or raccoons, respectively, have been known for many years.
CPV is closely related to FPV, RPV, and MEV. Those viruses are all >98% similar in DNA sequence within the capsid protein gene (9, 27, 32, 33, 42, 43) , and studies with monoclonal antibodies (MAbs) indicate that the viruses are very similar antigenically (36, 38, 56) . However, there is a specific epitope on CPV which is not present on the other viruses, and there are also epitopes which can distinguish FPV and MEV isolates from CPV (36, 38, 56) . In addition, the CPV isolates differ from FPV and MEV in their pH dependence of hemagglutination (HA), as the CPV isolates hemagglutinate at all pH values between 6.0 and 8.0, while FPV isolates hemagglutinate only below about pH 6.8 (11, 29, 33) . The host ranges of CPV and FPV are complex, and there are differences in the results obtained from in vivo versus in vitro analysis (52) . CPV isolates replicate in dogs and in cultured canine cells as well as in many cultured feline cells. FPV isolates replicate systemically in cats and in cultured feline cells but not in cultured canine cells (3, 10, 33, 52) . However, CPV does not appear to replicate in cats after parenteral inoculation, while FPV replicates in vivo in the * Corresponding author. canine thymus and possibly bone marrow but not in other tissues (52) .
Studies of recombinants between CPV and FPV indicate that sequence differences which affect the canine host range and antigenic type of CPV are located within the VP1 and VP2 genes, between 59 and 73 map units (m.u.) (32, 33, 37) . There are eight coding nucleotide differences in the 59 to 100 m.u. region between the prototype strains CPV-d and FPV-b (36, 39) . Five of those are phylogenetically conserved among CPV isolates and differ in the sequences of the viruses from other species (32, 33) . Earlier analysis of CPV/FPV recombinants indicated that the pH dependence of HA was determined by the region between 59 to 80 m.u. and that it was specifically affected by VP2 residue 375 (32, 33) .
Antigenic drift with strain replacement has been described among recent isolates of CPV, with two or three epitopes varying between virus strains (34, 40) . However, none of the CPV-specific sequences within the 59 to 73 m.u. region changed during that variation.
The atomic structures of CPV full and empty particles and of FPV empty particles have been solved by X-ray crystallography (1, 53, 54) (8) . Expression of the viral nonstructural protein NS2 was also found to be essential for the lymphotropic phenotype of MVM (8) . Studies on the in vitro host range of porcine parvovirus (PPV) showed that the host specificity was determined intracellularly (30, 44) . A PPV mutant which was adapted to canine A72 cells had changes within both the nonstructural protein and capsid protein gene regions which were involved in host range determination (55) .
In this study, we used site-directed mutagenesis and recombination mapping of the infectious plasmid clones of CPV and FPV to define the precise roles of each of the specific sequences within the 59 to 73 m.u. region in the determination of in vitro canine host range, the pH dependence of HA, and the CPV-and FPV-specific epitopes of these viruses.
(Some of these data have been presented in abstract form at the Keystone Meeting on the Cell Biology of Virus Entry, Replication and Pathogenesis [39] .) MATERIALS AND METHODS Cells and viruses. NLFK feline kidney-derived cells (14) and A72 canine fibroma-derived cells (7) were grown in a mixture of 50% McCoy's SA and 50% Leibovitz L15 media with 5% fetal bovine serum. The A72 cells were used at passage levels between 145 and 160.
CPV-d (CPV type 2) and FPV-b were derived from the infectious plasmid clones of those viruses (pBI265 and pBI292, respectively [32] ) after transfection of NLFK cells.
Mutagenesis and recombination. To simplify the genetic analysis, a clone that contained the HindIII-HaeIII sequence (m.u. 49 to 75) of the FPV-a isolate (mBI100 in the M13 mp18 vector) (33) was used for mutagenesis. That FPV-a sequence contained only three coding (nucleotides [nt] 3065, 3094, and 3753) differences and one noncoding (nt 3485) difference from the CPV-d sequence within the 59 to 73 m.u. (PstIPvuII) region analyzed here (33) (Fig. 1A) . That clone was mutagenized as depicted in Fig. 1B , using the method described by Kunkel (24) . M13 single-stranded DNA substituted with uracil by growth in Escherichia coli CJ236 (dut-1 ung-1) was used as a template for synthesis of a mutant strand by priming with a synthetic oligonucleotide, and then mutants were selected by growth in the wild-type MV1190 strain.
After recloning into plasmids, various sequence combinations were prepared by recombination at an SpeI site (nt 3459) ( Fig. 1B and 2 ). Each sequence was used to reconstruct the infectious virus genome by substitution of the PstI-PvuII fragments (59 to 73 m.u.) into the infectious clones of CPV or FPV ( Fig. 2 and 3) . Recombinant tary to various VP1 and VP2 gene sequences (32, 33) . Characteristic restriction enzyme sites which differed between the recombinants were also examined in some cases in the replicative-form (RF) DNAs recovered from infected cells. The changed nucleotides in viruses vBI280, vBI288, and vBI282 (Fig. 3) Fig. 3 ) by replacing the SpeI-PacI region (68 to 91 m.u.) with the sequence from CPV-d (pBI265) (Fig. 3) , making a genome with the 59 to 91 m.u. region from CPV in an FPV background.
Transfection of cells and titration of viruses. CsCl-banded plasmids were transfected as 5-or 10-p,g amounts into the NLFK cell line by using calcium phosphate precipitation (17, 19) Fig. 1 ). All sequence combinations were inserted between PstI and PvuII sites of CPV-d (pBI265) or FPV-b (pBI292) infectious clones. The individual plasmids were identified as shown in Fig. 3 . essential medium at 500 V/cm for 15.3 ms, after which the cells were cultured in 25-cm2 flasks in growth medium. To isolate viruses, transfected cells were passaged blind one or two times. Viruses were titrated by an immune staining plaque assay (25, 37 (32, 33) .
RESULTS
One virus prepared in this study, vBI410, was a recombinant which contained the 59 to 91 m.u. region of CPV in the FPV background (Fig. 3) . That virus replicated in A72 cells approximately as well as did the wild-type CPV-d (Fig. 3 to 5), and it had the same antigenic type and pH dependence of HA ( Fig. 3 ; see also 8) , confirming that those properties were all contained within the 59 to 91 m.u. region (32, 33) . We examined the roles of viral sequences within the 59 to 73 m.u. region, which has been previously shown to influence host range and antigenic properties of the viruses (33), by preparing a series of mutants by site-directed mutagenesis and recombination ( Fig. 1 to 3 ). All amino acid positions refer to location in the VP2 sequence. Canine host range. Viable recombinant viruses were analyzed for their host ranges in NLFK and A72 cells by using three different assays: plaque formation, RF DNA formation, and in some cases growth curve analysis. The analysis of RF DNA revealed a low level of viral replication in some cases in which no plaques were detected by the plaque assay. This finding most likely indicates that the formation of a detectable plaque required multiple rounds of replication and secondary cell infections, and the lowered replication of some viruses (e.g., vBI286 and vBI279) resulted in foci of infected A72 cells which were too small to be detected by the autoradiographic method used in the plaque assay. The original wild-type CPV-d and those FPV recombinants which had CPV sequences at amino acids (aa) 93 and 323 (vBI319, vBI340, and vBI410) formed visible plaques in A72 cells in the plaque assay (Fig. 3B) , and those viruses also showed higher levels of RF DNA replication (Fig. 5A) of aa 93, 103, or 323 to FPV sequence lost the ability to plaque in A72 cells (Fig. 3) .
For efficient replication in A72 cells, CPV Asn-93 and Asn-323 were both required to be present in viruses with an FPV genetic background (vBI319, vBI340, and vBI410) (Fig.  4 and 5 ). For viruses with a CPV background, the single changes of either Asn-93 to Lys (vBI280) or Asn-323 to Asp (vBI279) greatly reduced viral replication in A72 cells (Fig.  4) . When Asn-93 and Ala-103 both were replaced by the FPV sequences (vBI286 and vBI288), viral DNA replication in A72 cells was essentially abolished (Fig. 4) .
Although recombinants vBI319 and vBI340 replicated in A72 cells, both the RF DNA production (Fig. 5A ) and the relative growth (Fig. 6B ) of those viruses were lower than for CPV-d. Since the recombinant which contained the entire 59 to 91 m.u. region of CPV (vBI410) (Fig. 3) quences between 73 and 91 m.u. are also required for the full expression of the canine host range as seen in A72 cells. Three of the plasmid clones (pBI281, pBI287, and pBI337) were inviable, and no virus could be recovered after transfection or electroporation into either NLFK or A72 cells. The 59 to 73 m.u. region of each of those plasmids which had been subjected to mutagenesis was confirmed by sequencing from one strand, and the PflMI (nt 2814)-to-EcoRV (nt 4011) region (Fig. 1A) of each plasmid was recloned along with the remaining sequences from CPV-d (pBI265) or FPV-b (pBI292). Those plasmids remained inviable. This finding suggests that combinations of the CPV sequence at residue 93 (Asn) and the FPV sequence at residue 103 (Val) in the CPV background (vBI281 and vBI287), or combinations of CPV sequences at residues 93 (Asn) and 103 (Ala) along with FPV sequence at residue 323 (Asp) in the FPV background (vBI337), resulted in inviable plasmids (Fig. 3) .
Antigenic epitope analysis. The sequences affecting the CPV-or FPV-specific epitopes were analyzed by testing viruses with specific MAbs in the HI assay (Fig. 3C) and ELISA (Fig. 7) . Both tests clearly revealed the presence or absence of the CPV-specific epitope ( Fig. 3C and 7B) . The FPV-specific epitopes recognized by MAbs G and H were not as clearly distinguished by either HI or ELISA (Fig. 3C,  7D , and 7E), as previously described (36) . However, those FPV-specific MAbs showed both lower ELISA binding and lower HI titers to CPV and to certain mutant viruses (Fig.  3C, 7D, the same HI or ELISA titers as did wild-type FPV. The effects of multiple residues in determining the epitope recognized by MAb H were also observed ( Fig. 3 and 7) . Residues affecting pH dependence of HA. Previous studies indicated that sequences affecting the pH dependence of HA mapped between 59 and 80 m.u. (6, 32, 33) . However, as shown in Fig. 8 (Fig. 8) .
DISCUSSION
The origin of CPV has been of interest since it emerged in 1978 as the cause of a panzootic outbreak of disease in dogs. Because of the close antigenic and genetic relationship to FPV, it has long been suggested that CPV was derived as a variant of FPV which distinguish CPV and FPV map in the capsid protein gene (32, 33) . Here we examined in detail the functional roles of each of the coding sequence differences between 59 and 73 m.u. No function has been associated with the noncoding change of nt 3485 within that region, and that mutation was not examined separately.
The CPV-specific epitope associated with the single sequence Asn-93 has been found on all CPV isolates that we have tested to date (34) , and Asn-93 is also observed in all reported CPV sequences (33, 34, 42, 43) . The FPV-specific epitopes were examined by HI testing and ELISA ( Fig. 3  and 7) . The epitope recognized by MAb G was affected by the difference of residue 323 (Asn-Asp), although both the HI and ELISA analyses showed intermediate titers with the mutant viruses. The residues affecting the epitope recognized by MAb H were not clearly defined in these studies.
The ability of CPV to replicate efficiently in A72 canine cells was found to map between 59 and 91 m.u. in the viral genome, i.e., in the right-hand 84% of the VP2 gene and 111 bases of the right-hand noncoding region (Fig. 3 , SB, and 6A). That canine host range was determined by combinations of several amino acids. A combination of the CPVspecific sequences at nt 3065 (Asn-93) and 3753 (Asn-323) introduced into FPV allowed it to replicate in A72 cells (Fig.  3 and 5 ), albeit to a lower level than did wild-type CPV (Fig.  6) 9 . Locations of the changes examined within the atomic structure of CPV as determined by X-ray crystallography. (A) Structure of the CPV capsid represented by grid mesh surfacing. The view is along the threefold axis, and the location of one VP2 a-carbon chain is shown in relation to an icosahedral face of the virus, which is outlined by a triangle. VP2 residues 93 and 323 on the surface of the capsid are shown, the different colors indicating the origin of each residue within the asymmetric unit of the virus is from a different, threefold-related VP2 molecule. The surface grid was calculated as originally described by Rossmann and Palmenberg (45) . (B) A stereo pair showing the interrelationships of the VP2 molecules around the threefold axis of symmetry of the virus capsid and showing the origins and locations of various residues that were examined in this study. The view is along the threefold axis, and the three VP2 molecules and the variable amino acids within each chain are indicated in red, blue, and yellow. Shading indicates the van der Waals radius of the atoms. the later CPV types compensated for the change of that residue back to the FPV sequence. Residue 323 is close in sequence alignment and probably also in capsid structure to the two changes in the MVM VP2 sequence (residues 317 and 321) which coordinately determine the ability of that virus to replicate in fibroblasts (5, 18) .
The host ranges of these viruses are complex, and the in vitro host ranges assayed here do not necessarily reflect the true animal host ranges. After inoculation in vivo, FPV-b replicated in the thymus and bone marrow cells of dogs but not in the intestine or in the peripheral or mesenteric lymph nodes (52) . We have previously shown that a recombinant virus similar to vBI319 but prepared from viral RF DNA replicated to high titers in the canine intestine and mesenteric lymph nodes (33) , indicating that the changes examined here most likely also define the ability of the virus to replicate systemically in dogs.
The biological significance of the pH dependence of HA is unknown, but this is a consistent difference between CPV and FPV. We have shown that the HA receptors of rhesus macaque erythrocytes which bind CPV are destroyed by neuraminidase or periodate treatment (6) , indicating that the viruses bind to sialic acid on glycoproteins or glycolipids on the erythrocyte surface. The CPV-like ability to hemagglutinate at a range of pH values up to at least 7.4 was affected by combinations of residues 323 and 375, in which the presence of the CPV Asn-375 predominated over the effect of the Asn-323-Asp sequence. However, when residue 375 was Asp, then the sequence of residue 323 determined the pH dependence of the erythrocyte binding. Residues 323 and 375 are in close proximity in the structure (Fig. 9) , probably allowing them to influence the same function. Analysis of two MAb-selected escape mutants of CPV which had mutations either of Asp-375 and Asp-302 or of Asp-323 and Arg-224 showed that both viruses had CPV-like HA dependence on pH (12) , supporting the results presented here. In addition, a non-HA mutant of CPV had a mutation of residue 377 from Arg to Lys which eliminated all virus binding to erythrocytes (6, 35) . Residue 375 reverts to the FPV sequence (Asp) in the CPV type 2a and CPV type 2b virus strains (33, 34) . While that change would not have affected the pH dependence of HA of those CPV strains since residue 323 was still Asn (Fig. 8) , it may have affected the temperature dependence of HA, which is a marker for the later CPV strains (47) . Various pH-induced changes have been reported for other viruses, including picornavirus (23) and polyomavirus (15, 16) . Mengovirus had a higher infectivity as a result of a conformational change around the pit structure caused by exposure to a low-pH condition, and that pit structure was shown to be the receptor attachment site (23) . A single amino acid change in polyomavirus VP1 affected the viral plaque size and pH dependence of HA (16) and was also involved in determining the tissue tropism of that virus (15) . That residue was located on the outside of the viral capsid in a region thought to be involved in receptor attachment (16) .
The locations of the residues examined here are shown in the CPV capsid structure in Fig. 9 . All of the changes are within the elaborated loops which make up the threefold spikes of the virus capsid. The changes Asn-93-Lys and Asn-323--3Asp may both influence interactions between residues in neighboring loops of either the same VP2 molecule or the threefold-related VP2 (Fig. 9) . Residue Ala-103-Val may not directly influence the host range, but as it is close to residue 93 (Fig. 9) , it may be involved in compensating for the Asn-93 sequence in CPV, allowing virus viability (Fig.  3) . The structure of FPV empty particles has recently been determined and has revealed significant differences in the conformations of the loops which make up the threefold spike around these differences in sequence (1) . This finding may be similar to the results of studies of poliovirus host range mutants, wherein residues outside the receptor binding canyon were found to affect host and tissue tropism by changing the conformation of loops around the fivefold axis of the viral structure (26, 57) .
The differences between CPV and FPV capsids may affect some early stage involving attachment, entry, uncoating, or initiation of DNA replication of virus during infection, as has been observed for the tissue tropisms of MVM and PPV (5, 30, 44, 50) . Our studies have shown that the restriction of the replication of FPV in canine cells was at an early stage of infection, prior to DNA replication (Fig. 4 and 5) , and the FPV genome was expressed efficiently in A72 cells after DNA transfection (12) . It has been suggested that the receptor is not the determinant of tissue tropism of MVM (50) or PPV (30, 44, 55) . A lack of receptor appears to be unlikely to be the major block in the replication of FPV in canine cells; for example, in Fig. 4 
